# Psychiatry (eating disorders) Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Diana, Princess of Wales (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML028-SYN
- Date: 2026-02-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Thea Rosenthal, MD
- Calendar frame: modern shifted

- Requested by: Imogen Castleford, MD

## Reason for consultation

Bulimia nervosa, severe, in a 28-year-old woman who asked for help after about three years of binge eating with self-induced vomiting, now about ten times a week, with low potassium and moderate depression. Please confirm the diagnosis and severity, advise on the level of care, the psychological treatment, and fluoxetine, and set the medical monitoring and the thresholds for a higher level of care. **S**

## History

Ms. Spencer, a 28-year-old charity worker, is seen at the request of Dr. Castleford one week after she first asked for help. For about three years she has restricted her eating through the day and binged in the evenings, each binge followed by self-induced vomiting; this week there were seven episodes, from about ten the week before. The binges bring brief comfort and then shame. She judges herself largely by her shape and weight. She has never used laxatives, diuretics or diet pills and does not exercise to compensate. She has had no fainting, palpitations, weakness, or blood in the vomit. For about two months she has been low, tired, and hopeless, and she had an earlier depression after childbirth. She has no current thoughts of suicide or self-harm; past self-injury is part of her history, and there has been none for years. She drinks a little at weekends and uses no drugs. She wants to stop and is willing to start treatment now. **S**

## Examination

| System | Finding |
|---|---|
| General | Well; lying blood pressure 104/66 and pulse 68, standing 100/64 and pulse 84 |
| Head and neck | Bilateral parotid enlargement; enamel erosion on the inner surfaces of the upper front teeth |
| Mental status | Tearful at times but engaged and articulate; mood low; organized; no psychotic features; no suicidal thoughts; insight good |

BP 104/66 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 99% on room air; weight 61.2 kg; BMI 19.3 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Castleford's intake note, safety assessment, and safety plan. Intake: potassium 3.1, chloride 94, bicarbonate 32 mmol/L; magnesium 1.8 and phosphate 3.4 mg/dL; amylase 146 U/L; creatinine 0.84 mg/dL; QTc 452 ms; PHQ-9 14; SCOFF 4 of 5; EDE-Q global score 3.9. Today: potassium 3.6, chloride 99, bicarbonate 28 mmol/L, creatinine 0.80 mg/dL; PHQ-9 13; weight 61.2 kg, BMI 19.3; her self-monitoring record for the week. Sodium: 139 mmol/L; Potassium: 3.6 mmol/L; Chloride: 99 mmol/L; Bicarbonate (total CO2): 28 mmol/L; Creatinine: 0.8 mg/dL; eGFR: 103 mL/min/1.73 m²; PHQ-9: 13. All results are synthetic.

## Assessment

1. **Bulimia nervosa, severe** (F50.23). She meets the DSM-5-TR criteria: recurrent binge eating with a sense of loss of control, recurrent self-induced vomiting to prevent weight gain, both at least weekly for more than three months, and self-evaluation unduly shaped by weight and shape, without the low weight of anorexia nervosa. With about seven to ten compensatory episodes a week it is severe. Outpatient care is safe: potassium has risen to 3.6 mmol/L on oral replacement, the QTc is below 460 ms, she has not fainted, and the pulse rise on standing is modest. Because the illness is severe and has lasted years, eating-disorder-focused CBT (CBT-E) is a better choice than guided self-help. Fluoxetine 60 mg daily has the most evidence in bulimia nervosa and also treats her depression, so it should start now rather than after six weeks of psychotherapy alone. Bupropion should be avoided because of the risk of seizures in bulimia nervosa. **S**
2. **Major depressive disorder, recurrent, moderate** (F33.1). A moderate depressive episode, recurrent given the earlier depression after childbirth. It often improves as bingeing and vomiting settle; fluoxetine treats both. Her risk of self-harm is higher with both conditions, so the safety plan should be reviewed at every visit, especially in the first weeks of fluoxetine. **S**
3. **Hypokalemia from vomiting** (E87.6). Mild and improving on oral replacement. It should be checked weekly until normal twice and then at each visit while she vomits; magnesium should be checked again, because low magnesium keeps potassium low. **S**

## Recommendations

1. Outpatient care. Arrange urgent medical care, or a higher level of eating-disorder care, for potassium below 3.0 mmol/L despite replacement, QTc above 500 ms or new arrhythmia, fainting, a resting pulse below 50, vomiting she cannot control, blood in the vomit, or suicidal thoughts.
2. Eating-disorder-focused CBT (CBT-E): 20 sessions over 20 weeks with an eating disorders therapist, twice weekly for the first four weeks, starting this week, with regular eating, weighing in session, and a relapse-prevention plan at the end.
3. Start fluoxetine 20 mg each morning, increase to 40 mg after one week and 60 mg after two weeks; a nurse phone check one to two weeks after starting for side effects, agitation, and suicidal thoughts; continue for at least a year after remission. Avoid bupropion.
4. Continue potassium chloride 20 mEq twice daily until potassium is normal on two checks; electrolytes and creatinine weekly until then and at each medical visit while vomiting continues; repeat magnesium at the next check.
5. Repeat the ECG two weeks after reaching fluoxetine 60 mg, because potassium has been low.
6. A dental examination soon, with no brushing for an hour after vomiting, a non-acid fluoride mouthwash, and fewer acidic drinks.
7. Continue the eating disorders dietitian for regular eating; no dieting.
8. Measure the PHQ-9 at each visit and the EDE-Q at mid-treatment and at the end; review safety at every visit.

## Strengths and supports

- Works full time for charities that support homeless young people, people with disabilities, and people living with HIV; travels often for her work and enjoys meeting the people it serves **S**
- Supports: her friends and her work, which gives her purpose; she wants care that is kept private and decides who is told about her health **S**

## Communication

Discussed with Dr. Castleford, who sees her the same day. The plan was explained to Ms. Spencer, who agreed to start CBT-E and fluoxetine; she decides who else receives this note. **S**

## Follow-up

Psychiatry review at the end of CBT-E if she is not in remission, and review of a fluoxetine taper after a year of remission. Dr. Castleford continues prescribing and medical monitoring. **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023), American Psychiatric Association (American Journal of Psychiatry 2023;180(2):167-171)
- Eating disorders: recognition and treatment (NICE guideline NG69) (2017, updated 2020), National Institute for Health and Care Excellence
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
